• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Advances in molecular profiling and categorisation of pancreatic adenocarcinoma and the implications for therapy.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    cancers-10-00017.pdf
    Size:
    447.3Kb
    Format:
    PDF
    Description:
    Open access full text article
    Download
    Authors
    Pihlak, Rille
    Weaver, Jamie M
    Valle, Juan W
    McNamara, Mairéad G
    Affiliation
    Division of Cancer Sciences, University of Manchester, Manchester M13 9NT, UK
    Issue Date
    2018-01-12
    
    Metadata
    Show full item record
    Abstract
    Pancreatic ductal adenocarcinoma (PDAC) continues to be a disease with poor outcomes and short-lived treatment responses. New information is emerging from genome sequencing identifying potential subgroups based on somatic and germline mutations. A variety of different mutations and mutational signatures have been identified; the driver mutation in around 93% of PDAC is KRAS, with other recorded alterations being SMAD4 and CDKN2A. Mutations in the deoxyribonucleic acid (DNA) damage repair pathway have also been investigated in PDAC and multiple clinical trials are ongoing with DNA-damaging agents. Rare mutations in BRAF and microsatellite instability (MSI) have been reported in about 1-3% of patients with PDAC, and agents used in other cancers to target these have also shown some promise. Immunotherapy is a developing field, but has failed to demonstrate benefits in PDAC to date. While many trials have failed to improve outcomes in this deadly disease, there is optimism that by developing a better understanding of the translational aspects of this cancer, future informed therapeutic strategies may prove more successful.
    Citation
    Advances in molecular profiling and categorisation of pancreatic adenocarcinoma and the implications for therapy. 2018, 10 (1) Cancers
    Journal
    Cancers
    URI
    http://hdl.handle.net/10541/620802
    DOI
    10.3390/cancers10010017
    PubMed ID
    29329208
    Type
    Article
    Language
    en
    ISSN
    2072-6694
    ae974a485f413a2113503eed53cd6c53
    10.3390/cancers10010017
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    • Authors: Qian Y, Gong Y, Fan Z, Luo G, Huang Q, Deng S, Cheng H, Jin K, Ni Q, Yu X, Liu C
    • Issue date: 2020 Oct 2
    • Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment.
    • Authors: Peters ML, Tseng JF, Miksad RA
    • Issue date: 2016 Jul
    • Genomic Profiling and Potentially Targetable Alterations in Pancreatic Ductal Adenocarcinoma.
    • Authors: Gleeson FC, Levy MJ
    • Issue date: 2018 Dec
    • Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.
    • Authors: Philip PA, Azar I, Xiu J, Hall MJ, Hendifar AE, Lou E, Hwang JJ, Gong J, Feldman R, Ellis M, Stafford P, Spetzler D, Khushman MM, Sohal D, Lockhart AC, Weinberg BA, El-Deiry WS, Marshall J, Shields AF, Korn WM
    • Issue date: 2022 Jun 13
    • The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma.
    • Authors: Shui L, Li X, Peng Y, Tian J, Li S, He D, Li A, Tian B, Li M, Gao H, An N, Yi C, Cao D
    • Issue date: 2021 Jul 12
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.